Skip to content
Minnetronix Medical
« Back to News
June 29, 2016 | FDA News

Minnetronix Raises $20M in Equity Capital

Minnetronix has raised $20 million in equity capital through a minority investment from Altaris Capital Partners.

View Article

Minnetronix Medical
1635 Energy Park Drive
St. Paul, MN 55108
P: 651-917-4060
neuro@minnetronixmedical.com

Minnetronix is a trademark of Minnetronix Medical, Inc. MindsEye is a trademark of Minnetronix Neuro, Inc.
Caution: Federal (U.S.A.) Law restricts this device to sale by or on the order of a physician.

Neurapheresis is a trademark of Minnetronix, Inc.
Caution: Investigational Device. Limited by Federal (U.S.A.) law to investigational use only.

DepiCT is a trademark of Minnetronix Neuro, Inc.
DepiCT Neuroimaging Platform is currently under development. All subsequent material represents intended use.

LinkedIn Facebook Twitter Twitter
© 2024 Minnetronix Medical. All rights reserved.